• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中淀粉样斑块和神经原纤维缠结的多示踪剂PET成像。

Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.

作者信息

Shin Jonghan, Lee Sang-Yoon, Kim So-Hee, Kim Young-Bo, Cho Seong-Jin

机构信息

Neuroscience Research Institute, Gachon University of Medicine and Science, Namdong-Gu, Incheon, Republic of Korea.

出版信息

Neuroimage. 2008 Nov 1;43(2):236-44. doi: 10.1016/j.neuroimage.2008.07.022. Epub 2008 Jul 23.

DOI:10.1016/j.neuroimage.2008.07.022
PMID:18694837
Abstract

Recently developed positron emission tomography (PET) tracers, such as PIB and FDDNP, help to visualize amyloid plaques and neurofibrillary tangles in living subjects. FDDNP binds to both amyloid plaques and tangles, whereas PIB selectively labels amyloid plaques. Therefore, it will be interesting to see a direct comparison of the regional binding of the two radiotracers for plaques (PIB) and plaques and tangles (FDDNP) using multitracer PET imaging for both PIB and FDDNP in the same subjects with and without Alzheimer's disease. Here we report that multitracer PET images of PIB and FDDNP in the same Alzheimer subjects show negligible PIB but strong FDDNP binding in the medial temporal cortex (hippocampus, amygdala, and parahippocampal gyrus), whereas there are significant quantities of both PIB and FDDNP binding in neocortical areas. These results suggest that tangles rather than amyloid plaques are the dominant pathology in the medial temporal cortex of living Alzheimer patients. In nondemented elderly normal subjects, PIB binding shows a significant increase in the posterior cingulate cortex compared with other brain regions, whereas in the same normal subjects we found significant FDDNP binding in the medial temporal cortex. Interestingly, the medial temporal FDDNP uptake values in normal elderly subjects were inversely correlated with long delay recall scores in the California Verbal Learning Test, a measure of episodic memory performance. We conclude that multitracer PET imaging of amyloid plaques and tangles using FDDNP and PIB in both nondemented and demented subjects provides important insight into these complicated pathological processes in living subjects.

摘要

最近研发的正电子发射断层扫描(PET)示踪剂,如匹兹堡化合物B(PIB)和氟代二氢脱氧葡萄糖(FDDNP),有助于在活体受试者中可视化淀粉样斑块和神经原纤维缠结。FDDNP能与淀粉样斑块和缠结都结合,而PIB则选择性地标记淀粉样斑块。因此,利用多示踪剂PET成像,在患有和未患有阿尔茨海默病的同一受试者中,直接比较这两种放射性示踪剂对斑块(PIB)以及斑块和缠结(FDDNP)的区域结合情况将会很有意思。在此我们报告,在同一阿尔茨海默病受试者中,PIB和FDDNP的多示踪剂PET图像显示,内侧颞叶皮质(海马体、杏仁核和海马旁回)中PIB结合可忽略不计,但FDDNP结合很强,而在新皮质区域则有大量的PIB和FDDNP结合。这些结果表明,缠结而非淀粉样斑块是活体阿尔茨海默病患者内侧颞叶皮质中的主要病理特征。在未患痴呆症的老年正常受试者中,与其他脑区相比,PIB结合在后扣带回皮质中显著增加,而在同一正常受试者中,我们发现内侧颞叶皮质中有显著的FDDNP结合。有趣的是,正常老年受试者内侧颞叶的FDDNP摄取值与加利福尼亚言语学习测试中的长时延迟回忆分数呈负相关,该测试是情景记忆表现的一项指标。我们得出结论,在未患痴呆症和患痴呆症的受试者中,使用FDDNP和PIB对淀粉样斑块和缠结进行多示踪剂PET成像,为了解活体受试者中这些复杂的病理过程提供了重要见解。

相似文献

1
Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.阿尔茨海默病中淀粉样斑块和神经原纤维缠结的多示踪剂PET成像。
Neuroimage. 2008 Nov 1;43(2):236-44. doi: 10.1016/j.neuroimage.2008.07.022. Epub 2008 Jul 23.
2
Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.基于体素的阿尔茨海默病 PET 成像三探针分析:PIB、FDDNP 和 FDG。
Neuroimage. 2010 Aug 15;52(2):488-96. doi: 10.1016/j.neuroimage.2010.04.013. Epub 2010 Apr 10.
3
PET of brain amyloid and tau in mild cognitive impairment.轻度认知障碍患者脑淀粉样蛋白和tau蛋白的正电子发射断层显像(PET)
N Engl J Med. 2006 Dec 21;355(25):2652-63. doi: 10.1056/NEJMoa054625.
4
Depression and anxiety symptoms are associated with cerebral FDDNP-PET binding in middle-aged and older nondemented adults.抑郁和焦虑症状与中老年非痴呆成年人的大脑FDDNP-PET结合有关。
Am J Geriatr Psychiatry. 2009 Jun;17(6):493-502. doi: 10.1097/jgp.0b013e3181953b82.
5
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.阿尔茨海默病典型病例中体内PiB-PET淀粉样蛋白成像的尸检相关性
Brain. 2008 Jun;131(Pt 6):1630-45. doi: 10.1093/brain/awn016. Epub 2008 Mar 12.
6
The merits of FDDNP-PET imaging in Alzheimer's disease.FDDNP-PET 成像在阿尔茨海默病中的优点。
J Alzheimers Dis. 2011;26 Suppl 3:135-45. doi: 10.3233/JAD-2011-0008.
7
Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia.认知状态、年龄和APOE-4基因风险对无痴呆症人群脑FDDNP正电子发射断层扫描成像的影响。
Arch Gen Psychiatry. 2009 Jan;66(1):81-7. doi: 10.1001/archgenpsychiatry.2008.516.
8
Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.正电子发射断层扫描放射性药物在脑β淀粉样蛋白成像中的应用。
Semin Nucl Med. 2011 Jul;41(4):283-99. doi: 10.1053/j.semnuclmed.2011.02.005.
9
Imaging of amyloid deposition in human brain using positron emission tomography and [18F]FACT: comparison with [11C]PIB.使用正电子发射断层扫描和[18F]FACT对人脑淀粉样蛋白沉积进行成像:与[11C]PIB的比较。
Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):745-54. doi: 10.1007/s00259-013-2620-7.
10
In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET.利用[11C]SB - 13正电子发射断层扫描(PET)对阿尔茨海默病β - 淀粉样蛋白进行体内成像。
Am J Geriatr Psychiatry. 2004 Nov-Dec;12(6):584-95. doi: 10.1176/appi.ajgp.12.6.584.

引用本文的文献

1
Multiplexed imaging of radionuclides.放射性核素的多重成像。
Nat Biomed Eng. 2025 Jun 20. doi: 10.1038/s41551-025-01406-8.
2
F-MK-6240 tau PET in patients at-risk for chronic traumatic encephalopathy.F-MK-6240 tau正电子发射断层扫描在慢性创伤性脑病高危患者中的应用
Mol Neurodegener. 2025 Feb 25;20(1):23. doi: 10.1186/s13024-025-00808-1.
3
aXonica: A support package for MRI based Neuroimaging.Axonica:一个基于磁共振成像的神经成像支持软件包。
Biotechnol Notes. 2024 Aug 22;5:120-136. doi: 10.1016/j.biotno.2024.08.001. eCollection 2024.
4
The Sensitivity of Tau Tracers for the Discrimination of Alzheimer's Disease Patients and Healthy Controls by PET.正电子发射断层扫描(PET)中 tau 示踪剂对阿尔茨海默病患者与健康对照者的区分敏感性。
Biomolecules. 2023 Feb 3;13(2):290. doi: 10.3390/biom13020290.
5
Identification of the Hub Genes in Alzheimer's Disease.阿尔茨海默病的枢纽基因鉴定。
Comput Math Methods Med. 2021 Jul 15;2021:6329041. doi: 10.1155/2021/6329041. eCollection 2021.
6
[F]FDDNP PET binding predicts change in executive function in a pilot clinical trial of geriatric depression.FDDNP PET 结合预测老年抑郁症临床试验中执行功能的变化。
Int Psychogeriatr. 2021 Feb;33(2):149-156. doi: 10.1017/S1041610219002047. Epub 2020 Jan 23.
7
Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development.中枢神经系统正电子发射断层扫描(PET)的进展:用于病理生理学和药物开发新成像靶点的最新技术。
Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):451-489. doi: 10.1007/s00259-019-04488-0. Epub 2019 Sep 21.
8
Changes of Myelin Organization in Patients with Alzheimer's Disease Shown by q-Space Myelin Map Imaging.q空间髓鞘图成像显示阿尔茨海默病患者髓鞘组织的变化
Dement Geriatr Cogn Dis Extra. 2019 Feb 6;9(1):24-33. doi: 10.1159/000493937. eCollection 2019 Jan-Apr.
9
Development and validation of a salivary tau biomarker in Alzheimer's disease.阿尔茨海默病唾液tau生物标志物的开发与验证
Alzheimers Dement (Amst). 2018 Apr 21;11:53-60. doi: 10.1016/j.dadm.2018.03.003. eCollection 2019 Dec.
10
Development of tau PET Imaging Ligands and their Utility in Preclinical and Clinical Studies.tau正电子发射断层扫描成像配体的研发及其在临床前和临床研究中的应用
Nucl Med Mol Imaging. 2018 Feb;52(1):24-30. doi: 10.1007/s13139-017-0484-7. Epub 2017 Jun 7.